Supply Chain | February 10, 2026
Entero Healthcare expands MedTech footprint with acquisition of Anand Chemiceutics
Anand Chemiceutics serves over 1,500 laboratories, hospitals, and government institutions
Anand Chemiceutics serves over 1,500 laboratories, hospitals, and government institutions
The board highlighted ongoing investments in Radiopharma, CDMO Sterile Injectables, and CRDMO businesses
Capital expenditure stood at Rs. 405 crore to date against a planned Rs. 700 crore for FY26
The pharmaceutical giant said it would pursue legal and regulatory action following Hims & Hers
The facility is dedicated to breakthrough innovations in laboratory instruments that detect infectious diseases, cancer, and blood disorders
As CRISPR and prime editing applications advance, researchers increasingly rely on longer guide RNAs to boost editing efficiency and reduce off-target effects
The new service delivers end-to-end support, managing every stage of an epigenomics project
A nationwide network of over 1,000 accredited clinical trial sites will be created to accelerate drug development timelines and enhance research credibility
The Union Budget makes a clear and timely choice by placing biopharma at the centre of India’s next manufacturing wave
Subscribe To Our Newsletter & Stay Updated
